2025中国生物材料大会在浙江绍兴举行 图为参展商向观众介绍产品。中新社记者 刘子琳 摄 编辑：熊思怡 图为观众查看展品。中新社记者 刘子琳 摄 图为参展商介绍生物3D打印机。中新社记者 刘子琳 摄 广告等商务合作，请点击这里 图为3D打印的内侧半月板。中新社记者 刘子琳 摄 本文为转载内容，授权事宜请联系原著作权人 图为现场人头攒动。中新社记者 刘子琳 摄 图为开幕式现场。中新社记者 刘子琳 摄 来源：中国新闻网 图为参展商向观众介绍新技术。中新社记者 刘子琳 摄 中新经纬版权所有，未经书面授权，任何单位及个人不得转载、摘编或以其它方式使用。 关注中新经纬微信公众号(微信搜索"中新经纬"或"jwview")，看更多精彩财经资讯。 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 奥精医疗科技股份有限公司（以下简称"公司"）于2024年8月向国家药监局递交了公司可吸收复合骨修 复材料医疗器械产品的注册申报资料。公司于近日收到国家药监局通知，公司可吸收复合骨修复材料医 疗器械产品获得批准。现将相关情况公告如下： 一、注册证内容 证件有效期：2025.09.25-2030.09.24 产品分类：三类 二、医疗器械基本情况 本次获得可吸收复合骨修复材料医疗器械产品是在现有产品技术（人工骨修复材料，注册证号： 20193131531）的基础上，引入可吸收聚酯材料，在具有前代产品优良的生物相容性及促进骨愈合能力 的前提下，进一步增加了材料强度，并增强了材料降解可控性，能够更好的满足临床中不同条件下的骨 缺损修复。奥精医疗拥有可吸收复合骨修复材料医疗器械产品的完全自主知识产权，产品关键技术是骨 修复材料领域的重大进展，是生物材料领域的原始创新，开辟了一条自主制备生物材料的新途径，达到 国际领先水平。 三、对公司的影响及风险提示 本次公司产品获得注册证，进一步完善了 ...

Core Viewpoint - The article highlights the growing trend of biomanufacturing in various industries, particularly in the automotive and food sectors, driven by consumer preferences for sustainable and animal-free products [7][12][27]. Industry Ecosystem Trends - Mercedes has introduced a new electric GLC model featuring an animal-free interior, marking a significant step in the adoption of biomanufactured materials in mainstream consumer products [7][10]. - The collaboration with AMSilk and Modern Meadow showcases the potential of spider silk protein and plant-based leather alternatives in automotive applications [8][9]. - AMSilk has scaled its spider silk protein production from kilograms to tons, emphasizing its environmental benefits and versatility in textiles [9]. - Modern Meadow's materials, made from plant proteins and biopolymers, have over 80% renewable carbon content, making them more sustainable than traditional materials [9]. - The Canadian government is investing CAD 32.5 million to develop plant-based proteins, enhancing local value chains and food supply resilience [12][13]. Potential Markets and Products - AMSilk has secured €52 million in funding to expand its production capacity for silk-based biopolymers, which are biodegradable and free from microplastics [17][18]. - Bellroy has launched a new line of tech accessories made from INNOVERA, a sustainable material that mimics leather while being animal-free [20]. - Xampla has raised $14 million to develop Morro materials, a plant protein-based alternative to single-use plastics, aiming to replace highly polluting plastic types [22][24]. - Greenitio is developing mushroom shell chitosan-based cosmetics, offering a cost-effective and high-performance alternative to traditional natural products [25][26]. - Aleph Farms is establishing a cultured meat facility in Switzerland, part of its global expansion strategy, with significant investment backing [36]. R&D Efficiency Acceleration - Arzeda has received nearly $6.3 million from the NSF to advance cell-free manufacturing through AI-designed enzymes, aiming to enhance production efficiency and expand product ranges [39][40].

Core Viewpoint - The event in Wuhan on August 18 celebrated the eighth Chinese Physician's Day and showcased the first batch of 112 core medical technologies, aiming to create a quality platform for medical technology innovation [1][2]. Group 1: Medical Technology Highlights - A total of 112 core medical technologies were released, categorized into three levels: 32 "Leading Technologies," 40 "Pioneering Technologies," and 40 "Fundamental Technologies" [1]. - "Leading Technologies" include world-first innovations such as the "Chen's pancreatic-intestinal anastomosis" technique and the "micro life pump" providing the lightest artificial heart globally [1]. - "Pioneering Technologies" feature advancements like a corneal transplantation technique that can treat three patients with one donated cornea and a "bionic multi-organ chip" technology that can replace human drug testing [1]. - "Fundamental Technologies" focus on widely applicable techniques, such as a "super minimally invasive" technique for immediate stone removal and a technique for acute ischemic stroke intervention that can be taught to clinicians through short-term training [1]. Group 2: Support Measures and Competitive Edge - The Wuhan Municipal Health Commission plans to implement support measures in platform construction, insurance policies, professional title promotions, funding, and publicity to enhance the impact of these technologies [1]. - The evaluation of core medical technologies highlights Wuhan's competitive edge in various fields, particularly in hepatobiliary and gastrointestinal diseases, gynecological tumors, organ transplantation, cardiovascular diseases, and urological diseases [2]. - The application of cutting-edge technologies such as brain-computer interfaces, artificial intelligence, stem cell therapy, and biomaterials in Wuhan demonstrates significant breakthrough potential [2].

Core Insights - Wuhan has launched its first batch of core medical technologies, marking a significant step in establishing itself as an international medical innovation hub [1] - A total of 112 core medical technologies were released, with 617 projects submitted by 39 medical institutions during the evaluation process [1][2] - The technologies span various fields, showcasing high competitiveness in organ transplantation, gastrointestinal diseases, gynecological tumors, and cardiovascular diseases [1] Technology Classification - The 112 core medical technologies are categorized into three groups: - 32 "Leading Technologies" represent breakthrough innovations, including the globally recognized Chen's liver blood flow blockade method and the world's lightest artificial heart technology [2] - 40 "Pioneering Technologies" focus on improving traditional methods to address significant medical challenges, such as a corneal transplant technique that treats three patients with one donated cornea [2] - 40 "Fundamental Technologies" target common diseases and are suitable for widespread use in primary healthcare settings, like the "super minimally invasive" technique for immediate stone removal [2] Support Measures - The Wuhan Municipal Health Commission will implement support measures for the selected 112 core medical technologies, including platform development, insurance policies, professional title promotions, funding, and promotional activities [2]

Market Overview - A-shares experienced a narrow fluctuation in the morning session on July 4, with a strong performance driven by the banking sector, leading to all three major indices turning positive [2][4] - The Shanghai Composite Index rose by 0.41%, the Shenzhen Component Index increased by 0.05%, and the ChiNext Index gained 0.18% [4] - The FTSE A50 Index futures also saw an increase of nearly 1% during the session [4] Sector Performance - The banking sector led the market with a near 2% increase, with stocks like Shanghai Pudong Development Bank and Industrial Bank reaching historical highs [5] - Other sectors performing well included internet, public transportation, water services, software services, and insurance, while daily chemicals, mineral products, non-ferrous metals, and shipbuilding sectors faced declines [6] Concept Stocks - The digital currency concept saw significant gains, with stocks such as Jin Yi Culture, De Sheng Technology, and Jing Bei Fang hitting the daily limit [7] - The brain-computer interface concept also surged, with Bei Yi Kang rising over 17%, alongside other stocks like Ai Peng Medical and Innovation Medical [8] Regulatory Developments - On July 3, the National Medical Products Administration announced measures to optimize the lifecycle supervision of high-end medical device innovation, including special reviews for domestic and international leading innovations [10] - The announcement emphasized the need for improved communication between applicants and review experts, and support for high-quality development action plans related to high-end medical devices [10][11] Company-Specific News - In the Hong Kong market, Da Yang Group experienced a dramatic rise of nearly 75% after announcing a subscription agreement for 28.66 million shares at HKD 1.20 per share, representing approximately 19.99% of the existing shares [13][16] - Multi-Point Intelligence saw a rise of over 25% after announcing plans to apply for a stablecoin license and purchasing Bitcoin, responding to the Hong Kong government's push for Web3 industry development [17]

Core Insights - The article highlights a significant increase in the stock prices of companies involved in brain-computer interface technology, specifically Nanjing Panda Electronics, which rose by 14%, and MicroPort NeuroTech, which increased by 11% [1] Industry Developments - The National Medical Products Administration (NMPA) has announced measures to optimize the lifecycle regulation to support the innovation and development of high-end medical devices [1] - The announcement includes guidance for the registration of products related to artificial intelligence and biomaterials, indicating a regulatory push towards advanced medical technologies [1] - Policies supporting medical devices based on brain-computer interface technology are being developed in collaboration with relevant departments [1]

Market Overview - The US stock market saw significant gains, with the S&P 500 and Nasdaq indices reaching all-time closing highs for the third consecutive week. The Dow Jones increased by 0.77%, the S&P 500 rose by 0.83%, and the Nasdaq gained 1.02% [4] - Technology stocks generally performed well, with Nvidia rising by 1.3% to a market capitalization of $3.89 trillion, approaching Apple's record for the highest global market value. Amazon, Microsoft, Meta Platforms, and Alphabet also saw gains, while Tesla experienced a slight decline of 0.1% [4] - The Nasdaq Golden Dragon China Index rose by 0.40%, with notable increases in stocks like Xpeng Motors and iQIYI, while Alibaba and JD.com saw declines of over 1% [4] Economic Data - The US Labor Department reported an increase of 147,000 non-farm jobs in June, significantly exceeding analysts' expectations of 110,000, marking a 33% increase. The unemployment rate fell to 4.1%, better than the anticipated 4.3% [4] - Average hourly earnings rose by 0.2% month-over-month and increased by 3.7% year-over-year, indicating moderate wage growth that may help alleviate inflationary pressures [4] - The US Commerce Department reported that the trade deficit widened to $71.5 billion in May, surpassing the expected $70.9 billion, with exports decreasing by 4% to $279 billion and imports slightly declining to $350.5 billion [5] Company Announcements - Alibaba Group announced plans to issue zero-coupon exchangeable bonds totaling approximately HKD 12 billion, maturing in 2032, with proceeds aimed at cloud computing infrastructure and international e-commerce development. The bonds will reference Alibaba Health's shares listed in Hong Kong [9] - Hualing Steel reported that Xintai Life Insurance has acquired a 5% stake in the company, indicating potential future increases in their holdings [10][11] - Vanke A has applied for a loan of up to CNY 6.249 billion from Shenzhen Metro Group, which is also the largest shareholder with a 27.18% stake [12] - Changling Hydraulic announced that its controlling shareholders are planning a change in control, leading to a temporary suspension of its stock [13] - China Merchants Bank received approval to establish a wholly-owned subsidiary, China Merchants Financial Asset Investment Co., with a registered capital of CNY 15 billion, aimed at market-oriented debt-to-equity swaps and equity investment [14]

Group 1 - China's successful launch of the experimental satellite Tiankong-28B01 demonstrates the country's solid development in space technology, with the Long March 4B rocket completing its 583rd flight [1] - The satellite is primarily used for space environment detection and related technology experiments, reinforcing China's capability in autonomous space technology [1] Group 2 - Siemens announced that the U.S. government has lifted export restrictions on chip design software to China, allowing full access for Chinese customers to Siemens' software and technology [2] - This change indicates a potential easing of trade tensions and could enhance collaboration in the technology sector between the U.S. and China [2] Group 3 - The National Medical Products Administration of China is implementing supportive policies for high-end medical devices based on brain-computer interface technology, aiming to optimize the innovation review process [3] - The initiative includes special reviews for innovative medical devices with significant clinical value, enhancing communication between applicants and review experts [3] - The regulatory framework aims to accelerate the market entry of high-end medical devices, ultimately improving accessibility to advanced medical technologies for patients [3]

Group 1 - The Ministry of Commerce reported that from January to May 2025, China's service trade grew steadily, with total service trade reaching 32,543.6 billion yuan, a year-on-year increase of 7.7%. Exports were 14,033.7 billion yuan, up 15.1%, while imports were 18,509.9 billion yuan, increasing by 2.7%. The service trade deficit was 4,476.2 billion yuan, a decrease of 1,352.2 billion yuan compared to the same period last year [2] - The Ministry of Industry and Information Technology held a meeting focusing on accelerating the high-quality development of the photovoltaic industry, emphasizing the need to address low-price disorderly competition and guide companies to improve product quality [2] - The Tianjin Municipal Government is seeking public opinion on the "Tianjin Science and Technology Finance Action Plan (2025-2027)", which aims to establish a regional equity market to support 300 companies and create a listing reserve of 100 technology companies [3] Group 2 - The National Medical Products Administration announced measures to optimize the lifecycle supervision of high-end medical devices, including special reviews for innovative medical devices with significant clinical value and support for products based on brain-computer interface technology [4] - Companies such as Liu Steel and Huazhong Steel are experiencing stock fluctuations, with Liu Steel facing potential irrational speculation risks and Huazhong Steel being acquired by a major shareholder [5] - Aerospace Morning Light has regained its qualification for military material engineering service procurement [6]